See more : Longyan Kaolin Clay Co., Ltd. (605086.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Pideka Group Inc. (CIMVF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Pideka Group Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- VTEX (VTEX) Income Statement Analysis – Financial Results
- QuidelOrtho Corporation (QDEL) Income Statement Analysis – Financial Results
- PT Lionmesh Prima Tbk (LMSH.JK) Income Statement Analysis – Financial Results
- Prithvi Exchange (India) Limited (PRITHVIEXCH.BO) Income Statement Analysis – Financial Results
- Calvin B. Taylor Bankshares, Inc. (TYCB) Income Statement Analysis – Financial Results
Pideka Group Inc. (CIMVF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.iknkbrands.com
About Pideka Group Inc.
Ikänik Farms, Inc. operates as an integrated cannabis cultivator, producer, distributor, and dispensary operator in California and Colombia. The company offers pharmaceutical grade cannabinoids, decarboxylated flower, finished CBD products, and finished ingredient cannabis oil for scientific and commercial sales. It provides its products under the Ikanik, Essentials, Ronen, and Rations brands. The company is headquartered in Toronto, Canada.
| Metric | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 4.10K | 113.34 |
| Cost of Revenue | 0.00 | 0.00 | 3.56K | 116.33 |
| Gross Profit | 0.00 | 0.00 | 535.99 | -2.99 |
| Gross Profit Ratio | 0.00% | 0.00% | 13.07% | -2.63% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 7.62K | 6.74K |
| Selling & Marketing | 0.00 | 0.00 | 243.36 | 457.76 |
| SG&A | 0.00 | 0.00 | 91.03K | 271.19K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 0.00 | 0.00 | 91.03K | 271.19K |
| Cost & Expenses | 0.00 | 0.00 | 91.03K | 271.19K |
| Interest Income | 0.00 | 0.00 | 3.07K | 2.03K |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 228.49K | 236.56K | 1.43K | 594.52 |
| EBITDA | 0.00 | 0.00 | -91.03K | -271.19K |
| EBITDA Ratio | 0.00% | 0.00% | -2,220.58% | -239,264.89% |
| Operating Income | 0.00 | 0.00 | -91.03K | -271.19K |
| Operating Income Ratio | 0.00% | 0.00% | -2,220.58% | -239,264.89% |
| Total Other Income/Expenses | 0.00 | 0.00 | 2.00 | 0.00 |
| Income Before Tax | 0.00 | 0.00 | -91.03K | -271.19K |
| Income Before Tax Ratio | 0.00% | 0.00% | -2,220.53% | -239,264.89% |
| Income Tax Expense | 0.00 | 0.00 | 0.80 | 0.80 |
| Net Income | 0.00 | 0.00 | -91.03K | -271.19K |
| Net Income Ratio | 0.00% | 0.00% | -2,220.53% | -239,264.89% |
| EPS | 0.00 | 0.00 | -0.01 | -0.03 |
| EPS Diluted | 0.00 | 0.00 | -0.01 | -0.03 |
| Weighted Avg Shares Out | 0.00 | 0.00 | 9.50M | 9.33M |
| Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 9.50M | 9.33M |
Source: https://incomestatements.info
Category: Stock Reports